Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Drugs

Issue 9/2024

Content (12 Articles)

Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine

Benjamin J. Cowling, George N. Okoli

Targeting DNA Damage Response Deficiency in Thoracic Cancers

  • SCLC
  • Leading Article

Aleksandra Bzura, Jake B. Spicer, Sean Dulloo, Timothy A. Yap, Dean A. Fennell

RET Inhibitors in RET Fusion-Positive Lung Cancers: Past, Present, and Future

Monica F. Chen, Matteo Repetto, Clare Wilhelm, Alexander Drilon

Therapeutic Potential of FXI Inhibitors: Hype or Hope?

Mattia Galli, Giovanni Occhipinti, Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Salvatore Brugaletta, Davide Capodanno, Sebastiano Sciarretta, Dominick J. Angiolillo

Drug-Induced Pigmentation: A Review

Aaron Tisack, Tasneem F. Mohammad

Combination of PARP Inhibitors and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer

Louise Kostos, Ben Tran, Arun A. Azad

Bone Fragility in Diabetes and its Management: A Narrative Review

David Suphadetch Leungsuwan, Manju Chandran

Ivonescimab: First Approval

  • NSCLC
  • AdisInsight Report

Sohita Dhillon

Elafibranor: First Approval

Hannah A. Blair

Imetelstat: First Approval

Susan J. Keam

Ensifentrine: First Approval

Susan J. Keam

Correction: Elafibranor: First Approval

Hannah A. Blair

Aug 24
Issue: 8/2024
Oct 24
Issue: 10/2024

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images